CXCL8 and COVID-19: Emodin was reported to have potential to treat COVID-19 through its ability to act on a wide range of disease targets including BCL2L1, PTGS2, TP53, CASP3, CXCL8, EGFR, CSF2, MAPK14, FNT, VEGFA, MCL1, MAPK1, and 1L1B [132].